The IGF system and breast cancer - PubMed

Review

The IGF system and breast cancer

D Sachdev et al. Endocr Relat Cancer. 2001 Sep.

Abstract

The IGF system components have been implicated in breast cancer progression. IGF-I and IGF-II are mitogenic and anti-apoptotic peptides that influence the proliferation of various cell types including normal and transformed breast epithelial cells. The IGF system is a key growth regulatory pathway in breast cancer. As various components of the IGF system have been directly or indirectly implicated in breast cancer, it is essential to gain a better understanding of these in order to develop more specific therapeutic strategies for treating breast cancer.

Similar articles

• Interactions between the oestrogen and insulin-like growth factor signalling pathways in the control of breast epithelial cell proliferation.

  Westley BR, Clayton SJ, Daws MR, Molloy CA, May FE. Westley BR, et al. Biochem Soc Symp. 1998;63:35-44. Biochem Soc Symp. 1998. PMID: 9513709 Review.

• Insulin-like growth factor receptor expression and function in human breast cancer.

  Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N. Cullen KJ, et al. Cancer Res. 1990 Jan 1;50(1):48-53. Cancer Res. 1990. PMID: 2152773

• The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer.

  Yee D, Rosen N, Favoni RE, Cullen KJ. Yee D, et al. Cancer Treat Res. 1991;53:93-106. doi: 10.1007/978-1-4615-3940-7_5. Cancer Treat Res. 1991. PMID: 1672092 Review.

• The insulin-like growth factor system in advanced breast cancer.

  Helle SI. Helle SI. Best Pract Res Clin Endocrinol Metab. 2004 Mar;18(1):67-79. doi: 10.1016/s1521-690x(03)00045-9. Best Pract Res Clin Endocrinol Metab. 2004. PMID: 14687598 Review.

• Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines.

  De Leon DD, Bakker B, Wilson DM, Hintz RL, Rosenfeld RG. De Leon DD, et al. Biochem Biophys Res Commun. 1988 Apr 15;152(1):398-405. doi: 10.1016/s0006-291x(88)80727-7. Biochem Biophys Res Commun. 1988. PMID: 2451917

Cited by

• Effect of elevated basal insulin on cancer incidence and mortality in cancer incident patients: the Israel GOH 29-year follow-up study.

  Dankner R, Shanik MH, Keinan-Boker L, Cohen C, Chetrit A. Dankner R, et al. Diabetes Care. 2012 Jul;35(7):1538-43. doi: 10.2337/dc11-1513. Epub 2012 May 22. Diabetes Care. 2012. PMID: 22619079 Free PMC article.

• Functional roles and clinical values of insulin-like growth factor-binding protein-5 in different types of cancers.

  Güllü G, Karabulut S, Akkiprik M. Güllü G, et al. Chin J Cancer. 2012 Jun;31(6):266-80. doi: 10.5732/cjc.011.10405. Epub 2012 Feb 7. Chin J Cancer. 2012. PMID: 22313597 Free PMC article. Review.

• A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk.

  Allen NE, Roddam AW, Allen DS, Fentiman IS, Dos Santos Silva I, Peto J, Holly JM, Key TJ. Allen NE, et al. Br J Cancer. 2005 Apr 11;92(7):1283-7. doi: 10.1038/sj.bjc.6602471. Br J Cancer. 2005. PMID: 15756268 Free PMC article.

• Expression of nuclear insulin receptor substrate 1 in breast cancer.

  Sisci D, Morelli C, Garofalo C, Romeo F, Morabito L, Casaburi F, Middea E, Cascio S, Brunelli E, Andò S, Surmacz E. Sisci D, et al. J Clin Pathol. 2007 Jun;60(6):633-41. doi: 10.1136/jcp.2006.039107. Epub 2006 Aug 1. J Clin Pathol. 2007. PMID: 16882697 Free PMC article.

• Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort.

  Rinaldi S, Biessy C, Hernandez M, Lesueur F, dos-Santos-Silva I, Rice MS, Lajous M, Lopez-Ridaura R, Torres-Mejía G, Romieu I. Rinaldi S, et al. Int J Cancer. 2014 Mar 15;134(6):1436-44. doi: 10.1002/ijc.28469. Epub 2013 Oct 5. Int J Cancer. 2014. PMID: 24037648 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Sheridan PubFactory

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program